Urolesan (fir oil, wild carrot fruit) syrup 180 ml. vial

$26.00

Manufacturer: Ukraine

Acute and chronic cystitis and pyelonephritis; treatment of urolithiasis; prevention of urolithiasis; biliary dyskinesia, cholelithiasis; chronic calculous and non-calculous cholecystitis.

Category:

Description

Urolesan (fir oil, wild carrot fruit) syrup 180 ml. vial

Composition

active ingredients: 100 ml of syrup contains fir oil – 0.419 g, peppermint oil – 0.105 g, wild carrot fruit extract liquid extract Extractum fructum Dauci sativi fluidum (1: 1) (extractant 96% ethanol) – 1.204 g, hop cone extract liquid Extractum fructum Strobili lupuli fluidum (1: 1) (extractant 96% ethanol) (1,726 g), oregano herb extract of liquid Extractum herbae Origani fluidum (1: 1) (extractant 96% ethanol) – 1,195 g;

excipients: polysorbate-80; citric acid, monohydrate; sorbic acid; sugar syrup; edetate disodium; purified water.

Dosage form

Syrup.

Main physical and chemical properties: light yellow liquid with a greenish tinge, with a specific odor. Opalescence is allowed.

Pharmacotherapeutic group

Means used in urology. ATX code G04B X.

Pharmacological properties

Combined drug of plant origin. Ingredients of Urolesan syrup reduce inflammation in the urinary tract and kidneys, promote increased blood circulation to the kidneys and liver, have diuretic, antibacterial, choleretic effect, form a protective colloid in the urine and normalize the tone of the smooth muscles of the upper ureters and ureters. Urolesan syrup increases the excretion of urea and chlorides, helps to remove small stones and sand from the bladder and kidneys.

Indication:

  • acute and chronic urinary tract and kidney infections (cystitis and pyelonephritis);
  • urolithiasis and uric acid diathesis (prevention of concretions after their removal);
  • chronic cholecystitis (including calculous), biliary dyskinesia, gallstone disease.

Contraindications

Urolesan syrup is not prescribed in case of hypersensitivity to the components of this drug (which in the past have already observed allergic reactivity to any of the components of this drug), allergies to plants of the Hemp family, plants of the Umbrella family, plants of the Lamb family, hyperacid stomach inflammation (gastritis with high acidity) , peptic ulcer, erosive lesions of the stomach, 12-duodenum. Do not use the drug in case of large stones (3 mm).

Care should be taken when prescribing Urolesan in the form of a syrup to people with diabetes mellitus, as well as to patients with high blood sugar (sugar syrup is present in the drug). Caution during use is also needed in patients with bronchial asthma due to the risk of developing bronchospasm (a sharp narrowing of the bronchi). Children under the age of 14 are prescribed a drug in liquid form (syrup or solution). The drug in the form of a syrup cannot be administered to children under two years of age. If necessary, use in children under seven years of age, Urolesan syrup is used.

Application during pregnancy and lactation

The appointment of this pharmacological agent during pregnancy, breastfeeding has not been studied, therefore, the use is contraindicated.

Method of administration and dosage

The drug Urolesan should be taken orally before meals. A single dose, frequency of administration, duration of the course of treatment is determined by the doctor.

Syrup dosage: The recommended dose for adults is one teaspoon of syrup (5 ml) x 3 times / day. In acute conditions (including hepatic, renal colic), the duration of the course of treatment is 5-7 days, in chronic conditions – from seven days to a month. If renal / hepatic colic occurs, you can once increase a single dose to two teaspoons (10 ml), then return to the usual dosage (5 ml). Recommended doses for children: 2-7 years old – 2-4 ml x 3 times / day; 7-14 years old – 4-5 ml x 3 times / day. Dosing is carried out using a dosing syringe (complete with syrup).

Overdose

Signs of an overdose with Urolesan: possible vomiting, dizziness.

Overdose treatment: plentiful warm drink, intake of enterosorbent (activated carbon), rest, appointment of atropine sulfate (0.5-1 mg).

Side effects

Disorders from the digestive system: dyspeptic symptoms (heartburn, nausea, belching);

Disorders from the immune system: allergic manifestations in the form of itching, facial redness, skin rashes, angioedema (sore throat, shortness of breath, swelling of parts of the face, tongue), anaphylactic shock (severe itching of the skin, quickly spreading over the skin, sharp drop in blood pressure, vomiting, loose stools, laryngeal edema, noisy and labored breathing, pallor or cyanosis of the skin, a sharp narrowing of the bronchi and larynx, leading to acute difficulty in breathing, loss of consciousness, disorder of the vital organs);

Disorders from the central / peripheral nervous system: general weakness, dizziness, ataxia (impaired coordination of movements), headache, muscle tremor;

Disorders from the cardiovascular system: arterial hypotension / hypertension, bradycardia (slow heartbeat), pain in the heart.